Skip to content

Vivani Medical VANI Net Investment in Lease

Net Investment in Lease at other companies

Viking Therapeutics logo
Viking TherapeuticsVKTX
Wave Life Sciences logo
Wave Life SciencesWVE
Prime Medicine logo
Prime MedicinePRME
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's net investment in lease?
Vivani Medical (VANI) reported net investment in lease of $16.62M in Q1 2026.
How has Vivani Medical's net investment in lease changed year-over-year?
Vivani Medical's net investment in lease decreased by 5.2% year-over-year, from $17.52M to $16.62M.
What is the long-term trend for Vivani Medical's net investment in lease?
Over 4 years (2021 to 2025), Vivani Medical's net investment in lease has grown at a 80.8% compound annual growth rate (CAGR), from $1.61M to $17.23M.